Skip to Content

Xerese Approval History

  • FDA approved: Yes (First approved July 31st, 2009)
  • Brand name: Xerese
  • Generic name: acyclovir and hydrocortisone
  • Dosage form: Topical Cream
  • Previous name: Lipsovir
  • Company: Meda Pharmaceuticals Inc.
  • Treatment for: Cold Sores

Xerese (acyclovir and hydrocortisone) is a topical antiviral and anti-inflammatory combination for the prevention and treatment of cold sores.

Development History and FDA Approval Process for Xerese

Aug  4, 2009Approval The US FDA approves Lipsovir for marketing and sales in US
Dec  8, 2008Marketing Authorization Application for Lipsovir Now Validated by American and European Regulatory Authorities
Oct  1, 2008New Drug Application (NDA) for Lipsovir submitted to US FDA

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.